Cargando…
Changes in Iron Metabolism and Oxidative Status in STZ-Induced Diabetic Rats Treated with Bis(maltolato) Oxovanadium (IV) as an Antidiabetic Agent
The role of vanadium as a micronutrient and hypoglycaemic agent has yet to be fully clarified. The present study was undertaken to investigate changes in the metabolism of iron and in antioxidant defences of diabetic STZ rats following treatment with vanadium. Four groups were examined: control; dia...
Autores principales: | Sánchez-González, Cristina, López-Chaves, Carlos, Trenzado, Cristina E., Aranda, Pilar, López-Jurado, María, Gómez-Aracena, Jorge, Montes-Bayón, María, Sanz-Medel, Alfredo, Llopis, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913100/ https://www.ncbi.nlm.nih.gov/pubmed/24511298 http://dx.doi.org/10.1155/2014/706074 |
Ejemplares similares
-
Elucidating the Therapeutic Potential of Bis(Maltolato)OxoVanadium(IV): The Protective Role of Copper in Cellular Metabolism
por: Rivas-García, Lorenzo, et al.
Publicado: (2023) -
Effect of Bis(maltolato)oxovanadium(IV) on Zinc, Copper, and Manganese Homeostasis and DMT1 mRNA Expression in Streptozotocin-Induced Hyperglycemic Rats
por: Sánchez-González, Cristina, et al.
Publicado: (2022) -
Bis(maltolato)oxovanadium(IV) Induces Angiogenesis via Phosphorylation of VEGFR2
por: Parma, Laura, et al.
Publicado: (2020) -
Antidiabetic Bis-Maltolato-OxoVanadium(IV): Conversion of inactive trans- to bioactive cis-BMOV for possible binding to target PTP-1B
por: Scior, Thomas, et al.
Publicado: (2009) -
Bis maltolato oxovanadium (BMOV) and ischemia/reperfusion-induced acute kidney injury in rats
por: Almac, Emre, et al.
Publicado: (2014)